Granting data exclusivity for clinical trials would undermine access to medicines
The Hindu | 26 April, 2017
The compulsive patent hoarding disorder
The current model of commercialisation does not work for publicly funded research
The Hindu | 24 March, 2017
What To Watch Out For In The EU-Mercosur FTA Negotiations
Consequences For Access To Medicines
Intellectual Property Watch | 22 March, 2017
TPP is dead, but its legacy lives on
The Trans-Pacific Partnership was dead long before Donald Trump signed his executive order. But its damaging aspects, like stringent IP provisions, have just migrated to other agreements
